UCHealth University of Colorado Hospital (UCH)
12605 E. 16th Ave Aurora, CO 80045Phone: 720-848-0000
Lia Gore, MD
Pediatric Hematology / Oncology
Board Certified
Care Philosophy
I believe that each patient and each family require an individual approach appropriate to the needs and situation being faced. I work hard to ensure that the best and most complete information is available and try to work toward solutions and plans that meet people at the level at which they are most comfortable. I believe in a team-based approach that brings the best minds and ideas together to find the best options available.
Clinical Interest for Patients
I am interested in Phase 1 Clinical Trials with Special Emphasis on Acute Leukemias/Bone Marrow Transplant and Cell Therapies.
Title(s)
Ergen Family Chair in Pediatric Oncology, Section Head, Pediatric Hematology/Oncology/BMT
Credentials
Doctor of Medicine
Specialty
Pediatric Hematology / Oncology, Pediatrics
Scheduling Phone Number
720-777-1234
Gender
Female
Languages
English
Hospital Affiliation
Children's Hospital Colorado, University of Colorado Hospital
Children's Hospital Colorado Anschutz Medical Campus
Phone: 720-777-1234 720-777-1234
UCHealth Anschutz Outpatient Pavilion - Anschutz Medical Campus
1635 Aurora Ct Aurora, CO 80045Phone: 720-848-0000
University of Colorado Cancer Center
CU Anschutz Medical Campus
1665 Aurora Ct Aurora, CO 80045Phone: 720-848-0300
Provider Information
Specialties
- Pediatric Hematology / Oncology (2001,2017)
- Pediatrics (1996,2003)
Conditions
-
Cancers
Pediatric Cancer , Lung Cancer , Lymphoma , Chemotherapy , Cancer Medicine , Leukemia (Adult Acute) , Brain Cancer , Leukemia (Childhood) , Leukemia (Adult Chronic) , Bone Cancer
-
Brain and Nervous System
Brain Tumors
-
Blood / Lymphatic System
Blood Disorders
Interests and Activities
Volunteer Activities
Roundup River Ranch: a SeriousFun Network Camp
Carleton College
Department
Professor, Pediatrics-Heme/Onc and Bone Marrow Transplantation
Professional Memberships
American Association of Cancer Research, Full Member American Society of Clinical Oncology, Full Member American Society of Hematology, Full Member American Society of Pediatric Hematology/Oncology, Member Children’s Oncology Group, Member University of Colorado Cancer Center, Member
Research and Grants
Grants
A single-arm multicenter phase II study preceded by Dose Evaluation to investigate the efficacy, safety, and tolerability of the BiTE antibody blinatumomab in pediatric and adolescent patients with Relapsed/Refractory B-ALL (2012)
Experimental Therapeutics Program at Children’s Hospital Colorado (2014)
Southwest Early Clinical Trials Consortium (UM1) (2014)
Post-graduate Training in Pediatric Oncology (2015)
Precision-based Therapy for Childhood Leukemia Consortium Grant (2016)
Impact Grant (2017)
Pediatric Cancer Immunotherapy Trials Network (2017)
Cancer Center Support Grant - Senior Leaders (2017)
Children's Oncology Group NCTN Network Group Operations Center (2020)
Pediatric Early Phase Clinical Trials NetworkSub-award CFDA 93.395 “Agent Prioritization Committee” (2020)
Research Interests for Patients
I am interested in Phase I clinical trials and Clinical-Translational Research in novel cancer treatments, with a particular emphasis on leukemias, sarcomas, and pediatric brain tumors.
Education and Training
Medical Schools
MD, George Washington University School of Medicine and Health Sciences (1993)
Undergraduate Schools
BA, Carleton College (MN) (1987)
Internships
George Washington University/Children's National Medical Center Program (1994)
Residency Program
University of Colorado (Children's Hospital Colorado) Program (1996)
George Washington University/Children's National Medical Center Program (1994)
Fellowships
University of Colorado (Children's Hospital Colorado) Program (1999)
University of Colorado (Children's Hospital Colorado) Program (2001)
National Cancer Institute (2002)
Information for referring providers
Referral Contact Phone
720-777-1234
Referring Patients Link
Clinical Interests for Referring Providers
I am interested in Phase 1 Clinical Trials with Special Emphasis on Acute Leukemias/Bone Marrow Transplant-Cellular Therapies and new treatments for a variety of cancers.
Research Interest for Referring Providers
Phase I clinical trials and Clinical-Translational Research in novel cancer therapeutics and drug development for high risk pediatric cancers and for hematological malignancies.